Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
the NORPOD program. The work focuses on building a gene editing platform that can be used to correct patient-specific mutations in ex vivo cell therapies for monogenic immune diseases. We use high-throughput
-
Galej at the EMBL Grenoble, France. We are looking for a highly motivated and ambitious individual to join our team interested in the structure and function of RNA-protein complexes. Our group
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
on building a gene editing platform that can be used to correct patient-specific mutations in ex vivo cell therapies for monogenic immune diseases. We use high-throughput biology techniques to optimize
-
mucosal barrier damage and sensitivity to inflammation. Expected start date and duration of employment This is a 2.5–year position from October 1st, 2024, or as soon possible hereafter. Job description This
-
education to enable regions to expand quickly and sustainably. In fact, the future is made here. The Laboratory for Molecular Infection Medicine Sweden, MIMS, is the Swedish node for the Nordic EMBL
-
education to enable regions to expand quickly and sustainably. In fact, the future is made here. The Laboratory for Molecular Infection Medicine Sweden, MIMS, is the Swedish node for the Nordic EMBL
-
education to enable regions to expand quickly and sustainably. In fact, the future is made here. The Laboratory for Molecular Infection Medicine Sweden, MIMS, is the Swedish node for the Nordic EMBL
-
to be recruited will also be affiliated with the Laboratory for Molecular Infection Medicine Sweden (MIMS), a part of the Nordic EMBL Partnership for Molecular Medicine, and the Umeå Centre for Microbial